News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
26,558 Results
Type
Article (1008)
Company Profile (1)
Press Release (25549)
Section
Business (6348)
Career Advice (2)
Deals (1122)
Drug Delivery (1)
Drug Development (4064)
Employer Resources (3)
FDA (1551)
Job Trends (624)
News (13294)
Policy (1124)
Tag
Academia (108)
Alliances (1375)
Alzheimer's disease (79)
Approvals (1548)
Bankruptcy (5)
Best Places to Work (583)
Biosimilars (4)
Breast cancer (6)
Cancer (55)
Cardiovascular disease (18)
Cell therapy (9)
Clinical research (3345)
Collaboration (15)
COVID-19 (53)
C-suite (2)
Data (73)
Diabetes (7)
Diagnostics (110)
Drug discovery (3)
Earnings (2856)
Employer resources (3)
Events (3666)
Executive appointments (8)
FDA (1606)
Funding (12)
Gene editing (2)
Gene therapy (3)
GLP-1 (9)
Government (92)
Healthcare (640)
Infectious disease (54)
IPO (407)
Job creations (75)
Layoffs (4)
Legal (219)
Liver cancer (8)
Lung cancer (11)
Manufacturing (6)
Medical device (1609)
Medtech (1609)
Mergers & acquisitions (720)
Metabolic disorders (8)
Neuroscience (87)
NextGen Class of 2024 (178)
Non-profit (124)
Northern California (70)
Patents (10)
Patient recruitment (6)
People (1778)
Phase I (879)
Phase II (1498)
Phase III (1187)
Pipeline (26)
Postmarket research (179)
Preclinical (382)
Radiopharmaceuticals (4)
Rare diseases (7)
Real estate (123)
Regulatory (875)
Research institute (88)
Schizophrenia (2)
Series A (2)
Series B (2)
Sickle cell disease (4)
Southern California (31)
Startups (136)
United States (608)
Vaccines (5)
Webinars (3)
Date
Today (1)
Last 7 days (26)
Last 30 days (102)
Last 365 days (1350)
2024 (1338)
2023 (1553)
2022 (2105)
2021 (2020)
2020 (1841)
2019 (1597)
2018 (1267)
2017 (1366)
2016 (1194)
2015 (1558)
2014 (1306)
2013 (992)
2012 (1100)
2011 (1150)
2010 (1125)
Location
Africa (8)
Arizona (12)
Asia (1667)
Australia (252)
California (132)
Canada (46)
China (9)
Colorado (4)
Delaware (7)
Europe (2878)
Florida (44)
Georgia (6)
Illinois (12)
Indiana (3)
Japan (3)
Kansas (8)
Maryland (11)
Massachusetts (113)
Minnesota (29)
Nevada (4)
New Jersey (59)
New York (50)
North Carolina (62)
Northern California (70)
Ohio (5)
Pennsylvania (21)
South America (16)
Southern California (31)
Texas (22)
Utah (6)
Washington State (8)
26,558 Results for "cagent vascular".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Cagent Vascular Raises $30 Million Series C Financing
Cagent Vascular, Inc., a rapidly growing commercial stage medical device company, announced a Series C Financing close in excess of $30M. U.S. Venture Partners, led the round.
February 20, 2024
·
3 min read
Pharm Country
Cagent Vascular announces initial RECOIL Study results: Serranator demonstrates 49% less recoil than POBA in BTK arteries
Cagent Vascular, the exclusive developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its Below-the-Knee RECOIL study.
July 11, 2023
·
4 min read
Press Releases
CORRECTING and REPLACING Access Vascular Highlights New Midline Catheter Data at AVA 2024
Data Presented at the AVA Annual Scientific Meeting Shows Significantly Lower Complication and Failure Rates with Access Vascular’s HydroMID® Midline Catheter
October 2, 2024
·
2 min read
Pharm Country
Cagent Vascular announces superior lumen gain, greater volumetric blood flow using Serration Angioplasty: A sub-analysis of the PRELUDE BTK study
Cagent Vascular, the exclusive developer of Serration Angioplasty (Serranator®), announced the results of a comparative sub-analysis of the PRELUDE-Below-the-Knee (BTK) study versus Plain Old Balloon Angioplasty (POBA).
January 31, 2023
·
4 min read
Press Releases
LeMaitre Vascular Prices $150 Million Convertible Senior Notes
December 18, 2024
·
6 min read
Biotech Beach
Positive Interim Venous Ulcer Healing Data Showing Significant Improvement from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented Today at the Society for Vascular Surgery 2024 Vascular Annual Meeting
enVVeno Medical Corporation (NASFAQ:NVNO) (“enVVeno” or the “Company”) today announced that positive interim venous ulcer healing data showing significant clinical improvement from the SAVVE U.S. pivotal trial for the VenoValve will be presented today at the Society for Vascular Surgery 2024 Vascular Annual Meeting in Chicago.
June 21, 2024
·
6 min read
Pharm Country
Cagent Vascular Announces Commercial Launch of the Serranator Above-the-Knee (ATK) Product
Cagent Vascular Inc., a developer of next generation angioplasty balloons using serration technology, announced the expansion of its product offering to include larger balloons to treat superficial femoral and popliteal arteries in the Above-the-Knee (ATK) segment.
June 1, 2022
·
3 min read
Biotech Beach
New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024
enVVeno Medical Corporation (Nasdaq:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of venous disease, today announced that new interim venous ulcer healing data from the VenoValve U.S. pivotal trial will be presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting (VAM2024) being held June 18-22, 2024 in Chicago, IL.
June 17, 2024
·
5 min read
Biotech Beach
One-Year Results of the DETOUR2 Trial published in the Journal of Vascular Surgery (JVS)
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, has announced the online publication of the one-year results of the DETOUR2 Trial in the Journal of Vascular Surgery.
May 13, 2024
·
3 min read
Genetown
Access Vascular Announces New Bacterial Adhesion Data at INS 2024
Access Vascular, Inc. announced findings from new data showing a reduction in bacterial adhesion and thrombus accumulation in peripherally inserted central catheters and midline catheters with AVI’s MIMIX® hydrophilic biomaterial compared with conventional catheters.
May 21, 2024
·
4 min read
1 of 2,656
Next